« Let's Recap Public-Private R&D Collaborations | Main | Piramal finally falls to Abbott in India »

05/23/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0133ee4ba742970b

Listed below are links to weblogs that reference Is the "Big" in Big Pharma a value creator or a liability? :

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

Sanofi-Aventis has been successful in acquiring elements of its pipeline through small acquisitions. Its CEO says they remain on the hunt for further such opportunities - especially in the cancer area.
http://www.businessweek.com/news/2010-06-07/sanofi-ceo-sees-stunning-results-for-cancer-drug-update2-.html

bigredbruce

Zacks.com provides analysis of recent merger activity and what to look for in the coming year.
http://www.zacks.com/stock/news/33503/Pharma+&%3B+Biotech+Stock+Review+-+April+2010

bigredbruce

Fortune's take on Pharma and Biotech relationship coming out of BIO meetings in early June.
http://money.cnn.com/2010/05/10/news/companies/pharma_biotech_marriage.fortune/

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada